CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.55
+4.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 30.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 13.74x
- Price / sales
- 172.56x
- Price / cash flow
- -5.80x
Enterprise value
- Enterprise value
- $65.5M
- EV / sales
- 168.41x
- EV / EBITDA
- -5.45x
- EV / EBIT
- -5.06x
- Market cap
- $67.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026